Expression and clinical significance of GRIM-19 in non-small cell lung cancer

Chinese Journal of Cancer

Volumn 28, Issue 4, 2009, Pages 1-5

  Zhou, Ai Min ^a,b   Zhao, Ji Jing ^a   Ye, Jing ^a   Xiao, Wei Hua ^c   Kalvakolanu, Dhananjaya V ^d   Liu, Rong Yu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui College of Traditional Chinese Medicine   (China)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

GRIM 19; Immunohistochemistry; Laser scanning confocal microscopy; Lung neoplasm; Non small cell; Tumor suppressor

Indexed keywords

GENE ASSOCIATED WITH RETINOID INTERFERON INDUCED MORTALITY 19; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER STAGING; CELL NUCLEUS; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE LOCATION; GENE NUMBER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MALE; PRIMARY TUMOR; TISSUE LEVEL;

EID: 79955764597     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Alchanati I, Nallar SC, Sun P, et al. A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas [J]. Oncogene, 2006, 25(54): 7138-7147.
2. Gong LB, Luo XL, Liu SY, et al. Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma [J]. Aizheng, 2007, 26 (7): 683-687. [in Chinese]
3. Zhou J, Sun YE, Zhang LB. Preliminary study on the correlation between expression of CD44 in human non-small cell lung cancer and lymph node metastasis [J]. Chin J Lung Cancer, 2000, 3(2): 115-117. [in Chinese]
4. Angell JE, Lindner DJ, Shapiro PS, et al. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach [J]. Biol Chem, 2000, 275(43): 33416-33426.
5. Hofman ER, Boyanapalli M, Lindner DJ, et al. Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid [J]. Mol Cell Biol, 1998, 18(11): 6493-6504.
6. Lufei C, Ma J, Huang G, et al. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction [J]. EMBO J, 2003, 22(6): 1325-1335.
7. Kalakonda S, Nallar SC, Lindner DJ, et al. Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3 [J]. Cancer Res, 2007, 67(13): 6212-6220.
8. Zhang X, Huang Q, Yang Z, et al. GW112, a novel antiapoptotic protein that promotes tumor growth [J]. Cancer Res, 2004, 64(7): 2474-3481.
9. Barnich Nicolas, Hisamatsu T, Aguirre JE, et al. GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells [J]. Biol Chem, 2005, 280(19): 19021-19026.
10. Máximo V, Botelho T, Capela J, et al. Somatic and germline mutation in GRIM-19, a dual function gene in volved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid [J]. Br J Cancer, 2005, 92(10): 1892-1898.
11. Kalvakolanu DV. The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression [J]. Cytokine Growth Factor Rev, 2004, 15 (2-3): 169-194.
12. Huang G, Lu H, Hao A, et al. GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I [J]. Mol Cell Biol, 2004, (19): 8447-8456.